The Parkinson’s disease progression marker initiative (PPMI)

The Parkinson Progression Marker Initiative (PPMI) is a comprehensive, observational, international study designed to identify PD progression biomarkers.^2,4 The aim of the study is to improve the understanding of the causes of PD, and to provide tools to enhance future clinical trials of potential therapies.^2,4

References:
1.The Parkinson’s Progression Markers Initiative (PPMI). Study Protocol. October 2015.

2.PPMI website. PPMI-info.org. Accessed January 2025.

3.Marek K, Chowdhury S, Siderowf A, et al.; Parkinson’s progression markers initiative. The Parkinson’s progression markers initiative (PPMI) – establishing a PD biomarker cohort. Ann Clin Transl Neurol 2018; 5 (12): 1460–1477.

4.Parkinson Progression Marker Initiative. The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 2011; 95 (4): 629–635.